PuSH - Publikationsserver des Helmholtz Zentrums München

Ponce-de-Leon, M.* ; Wang-Sattler, R. ; Peters, A. ; Rathmann, W.* ; Grallert, H. ; Artati, A. ; Prehn, C. ; Adamski, J. ; Meisinger, C.* ; Linseisen, J.*

Stool and blood metabolomics in the metabolic syndrome: A cross-sectional study.

Metabolomics 20:105 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
INTRODUCTION/OBJECTIVES: Changes in the stool metabolome have been poorly studied in the metabolic syndrome (MetS). Moreover, few studies have explored the relationship of stool metabolites with circulating metabolites. Here, we investigated the associations between stool and blood metabolites, the MetS and systemic inflammation. METHODS: We analyzed data from 1,370 participants of the KORA FF4 study (Germany). Metabolites were measured by Metabolon, Inc. (untargeted) in stool, and using the AbsoluteIDQ® p180 kit (targeted) in blood. Multiple linear regression models, adjusted for dietary pattern, age, sex, physical activity, smoking status and alcohol intake, were used to estimate the associations of metabolites with the MetS, its components and high-sensitivity C-reactive protein (hsCRP) levels. Partial correlation and Multi-Omics Factor Analysis (MOFA) were used to investigate the relationship between stool and blood metabolites. RESULTS: The MetS was significantly associated with 170 stool and 82 blood metabolites. The MetS components with the highest number of associations were triglyceride levels (stool) and HDL levels (blood). Additionally, 107 and 27 MetS-associated metabolites (in stool and blood, respectively) showed significant associations with hsCRP levels. We found low partial correlation coefficients between stool and blood metabolites. MOFA did not detect shared variation across the two datasets. CONCLUSIONS: The MetS, particularly dyslipidemia, is associated with multiple stool and blood metabolites that are also associated with systemic inflammation. Further studies are necessary to validate our findings and to characterize metabolic alterations in the MetS. Although our analyses point to weak correlations between stool and blood metabolites, additional studies using integrative approaches are warranted.
Impact Factor
Scopus SNIP
Altmetric
3.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Blood Metabolomics ; Metabolic Syndrome ; Stool Metabolomics ; Systemic Inflammation; Gut Microbiota; Acid-metabolism; Bile-acids; Plasma
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 1573-3882
e-ISSN 1573-3890
Zeitschrift Metabolomics
Quellenangaben Band: 20, Heft: 5, Seiten: , Artikelnummer: 105 Supplement: ,
Verlag Springer
Verlagsort New York, NY
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Translational Genomics (ITG)
Institute of Epidemiology (EPI)
CF Metabolomics & Proteomics (CF-MPC)
Institute of Experimental Genetics (IEG)
POF Topic(s) 30205 - Bioengineering and Digital Health
30202 - Environmental Health
30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
Enabling and Novel Technologies
PSP-Element(e) G-506700-001
G-504000-010
G-504091-002
A-630710-001
G-500600-001
G-504090-001
Förderungen Projekt DEAL
Ludwig-Maximilians-Universitat Munchen, Germany
Munich Center of Health Sciences (MC-Health)
State of Bavaria
German Ministry of Education and Research (BMBF)
Helmholtz Munich - German Research Center for Environmental Health
Scopus ID 85204661375
PubMed ID 39306637
Erfassungsdatum 2024-09-27